Vasopressin V2 receptors, ENaC, and sodium reabsorption: a risk factor for hypertension?
about
New insights into sodium transport regulation in the distal nephron: Role of G-protein coupled receptorsPendrin as a novel target for diuretic therapyProtein- and diabetes-induced glomerular hyperfiltration: role of glucagon, vasopressin, and ureaThe Hypertension Pandemic: An Evolutionary Perspective.Antinatriuretic effect of vasopressin in humans is amiloride sensitive, thus ENaC dependent.Collecting duct principal cell transport processes and their regulation.Associations of epithelial sodium channel genes with blood pressure: the GenSalt studyMacrominerals and Trace Element Requirements for Beef CattleActivation of ENaC by AVP contributes to the urinary concentrating mechanism and dilution of plasma.Effect of increased water intake on plasma copeptin in patients with chronic kidney disease: results from a pilot randomised controlled trial.Regulation of transport in the connecting tubule and cortical collecting ductRole of Epithelium Sodium Channel in Bone Formation.Association between fluid intake and kidney function, and survival outcomes analysis: a nationwide population-based studyPlasma copeptin and renal outcomes in patients with type 2 diabetes and albuminuria.Randomized pilot trial comparing tolvaptan with furosemide on renal and neurohumoral effects in acute heart failure.Physiological regulation of magnocellular neurosecretory cell activity: integration of intrinsic, local and afferent mechanisms.Serum copeptin levels in adolescents with primary hypertension.Cyclic-AMP regulates postnatal development of neural and behavioral responses to NaCl in rats.Age dependency of vasopressin pulmonary vasodilatory effect in rats.Potential deleterious effects of vasopressin in chronic kidney disease and particularly autosomal dominant polycystic kidney disease.Vasopressin: a novel target for the prevention and retardation of kidney disease?Vasopressin regulation of sodium transport in the distal nephron and collecting duct.Involvement of ENaC in the development of salt-sensitive hypertension.Expression of adrenergic and cholinergic receptors in murine renal intercalated cells.Molecular mechanisms regulating aquaporin-2 in kidney collecting duct.Magnocellular Neurons and Posterior Pituitary Function.Is tolvaptan indicated for refractory oedema in nephrotic syndrome?Proximal tubule specific knockout of the Na⁺/H⁺ exchanger NHE3: effects on bicarbonate absorption and ammonium excretion.Vasopressin: physiology, assessment and osmosensation.Persistent high blood urea nitrogen level is associated with increased risk of cardiovascular events in patients with acute heart failure.Hyperosmolarity drives hypertension and CKD--water and salt revisited.Sodium channel Nax is a regulator in epithelial sodium homeostasis.Association of Genetic Variation in the Epithelial Sodium Channel Gene with Urinary Sodium Excretion and Blood Pressure.
P2860
Q26765204-491A9FC3-6910-4E31-BF2E-51280AE8CD8AQ26998714-F176170D-3EF7-49FD-A0C9-2993CF27DDAFQ28085593-174B209E-BB85-44B8-8BB4-D3B98F142F82Q30235938-04C7E684-3C8C-4266-9C24-911ABB9A9CCAQ34751826-71B1DE0D-650B-4CA0-9776-7EA482BC1B5EQ34828709-3EEC8B32-4147-4A63-9EEE-F65672C08F0EQ35171131-089D1284-0A71-4C88-A32E-5B5268FA6D1AQ35866317-F5B44838-F627-4F27-BEA0-1BAF0D8580CFQ36132542-6090C035-CEC0-4414-9D31-E57D48CA6D9BQ36329310-7AB1AD41-0AA2-48CB-86CB-C7F7FB6B317FQ36450027-63CDE896-B2D7-4FC6-8961-00E39E3213B6Q36720098-725ECAD6-E91C-4D0E-9D6E-B8C0971FA165Q36920040-3CCEDEA8-5487-4182-9E1C-8AC3CD5211ACQ37278044-839688ED-AAA9-4B0D-BC5F-F951A6B07B1CQ37352407-3EF5E6EA-B3B1-4BCE-836C-432F48E8DB5AQ37367369-C31AD366-9EF5-49A5-BE92-42A516174C29Q37554915-314D7557-86E0-4651-BE1B-754FE615F42AQ37638985-31063D40-4934-4ABD-A98B-1E7B3238B25DQ37701923-F0DD5F2F-C04A-4436-B276-6046B1963911Q37892306-BB96CA91-C50C-4E44-8FDF-1EB51BF8185CQ38084471-8099EA67-49E1-4662-B0C4-38DF088063EFQ38515104-05216BC6-BCB3-478D-BB57-482938E24787Q38779559-7E614D21-0A58-421C-8298-75BD1A601D69Q38971019-A3F7C274-17CE-4680-9964-DACC677BC053Q38985544-16BFDEB3-8170-4EF4-B2D0-C49064E09277Q38991468-9360445C-D361-4108-9B3F-93603196B8E0Q41529622-E19C47E0-0E9C-46F2-B0BE-A45DE7B0AF0DQ42155895-D119319C-CAA4-40B8-9D43-A17758B4E939Q47334957-3226EB74-E4BE-411E-9A55-D87B07BE416BQ48273049-D8A8DDE1-6BBF-405E-8186-E1ADFA118939Q48299673-5E2F56A1-D43E-4447-9075-0C5B12920B9CQ51658756-445CA550-48B5-4A7D-B754-BC52BEE2F7DAQ55352315-1026E078-5889-45B1-956F-5F44EFA52162
P2860
Vasopressin V2 receptors, ENaC, and sodium reabsorption: a risk factor for hypertension?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Vasopressin V2 receptors, ENaC, and sodium reabsorption: a risk factor for hypertension?
@en
Vasopressin V2 receptors, ENaC, and sodium reabsorption: a risk factor for hypertension?
@nl
type
label
Vasopressin V2 receptors, ENaC, and sodium reabsorption: a risk factor for hypertension?
@en
Vasopressin V2 receptors, ENaC, and sodium reabsorption: a risk factor for hypertension?
@nl
prefLabel
Vasopressin V2 receptors, ENaC, and sodium reabsorption: a risk factor for hypertension?
@en
Vasopressin V2 receptors, ENaC, and sodium reabsorption: a risk factor for hypertension?
@nl
P2860
P921
P1476
Vasopressin V2 receptors, ENaC, and sodium reabsorption: a risk factor for hypertension?
@en
P2093
Nadine Bouby
P2860
P304
P356
10.1152/AJPRENAL.00413.2010
P577
2010-09-08T00:00:00Z